Park Ha Biological Technology is trading at $2.44, up +5.64%, amid broader market risk-on sentiment.

  • The S&P 500 rose 1.02%, while the NASDAQ gained 0.95%, supporting risk appetite.
  • No credible company-specific announcement dated September 17, 2026 was identified.
  • Attention remains on the September 1 auditor change and securities-class-action notices, but neither is a new catalyst.